Peer-reviewedCC BYAlzheimer's & dementia : the journal of the Alzheimer's Association
Tyrosine kinase inhibitor use and risk of neurodegenerative disease: A Swedish population‐based cohort study
- 1Karolinska Institutet
- 2German Center for Neurodegenerative Diseases (DZNE)
Related
- Precarious employment and its impact on chronic obstructive pulmonary disease in the Swedish working population – a longitudinal register-based study
- A Novel ACLY Inhibitor Induces Transcriptional and Metabolic Reprogramming to Overcome Tyrosine kinase inhibitor Resistance in Lymphoma
- Aplastic Anaemia in a Chronic Lymphocytic Leukaemia Patient Treated With Acalabrutinib, a Bruton Tyrosine Kinase Inhibitor—Case Report
- Effectiveness of Adding GLP‐1 Receptor Agonists to SGLT2 Inhibitor Therapy in Chronic Kidney Disease: A Population Based Study
- A noncanonical function of the tyrosine degradation enzyme FAH drives CDK4/6 inhibitor resistance in breast cancer
BibTeX
@article{wittstrom2026tyrosine,
title = {{Tyrosine kinase inhibitor use and risk of neurodegenerative disease: A Swedish population‐based cohort study}},
author = {Felix Wittström and Enoch Yi‐Tung Chen and Iris Blotenberg and Torsten Dahlén},
journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13655210},
note = {CC BY},
}
RIS
TY - JOUR
TI - Tyrosine kinase inhibitor use and risk of neurodegenerative disease: A Swedish population‐based cohort study
AU - Felix Wittström
AU - Enoch Yi‐Tung Chen
AU - Iris Blotenberg
AU - Torsten Dahlén
PY - 2026
DA - 2026/10/01
JO - Alzheimer's & dementia : the journal of the Alzheimer's Association
UR - https://europepmc.org/article/PMC/PMC13655210
SN - 1552-5260
SN - 1552-5279
ER -